Assessing 18F-FDG Uptake in the Sentinel Lymph Node in Breast Cancer

Affiliations


Abstract

18F-FDG PET/CT has limited value in early breast cancer. Sentinel lymph node (SLN) biopsy is the current procedure of choice to search for small metastatic deposits in the axillary lymph nodes in early breast cancer. In this retrospective study, we reevaluated 18F-FDG PET/CT images after locating the SLN on PET/CT with the help of SLN SPECT/CT images and assessed 18F-FDG uptake, particularly in the SLN. Our goal was to understand if combined evaluation of 18F-FDG PET/CT and SLN SPECT/CT could be useful for detecting early lymph node metastasis in the axilla. 

Methods: 18F-FDG PET/CT images of newly diagnosed breast cancer patients who also had SLN scintigraphy (SPECT/CT) and biopsy results were analyzed to assess 18F-FDG uptake in the SLN. The SLN seen on SPECT/CT images was located on PET/CT images, and its metabolic activity was assessed both visually and semiquantitatively using SUVmax 18F-FDG PET results were compared with the histopathology result for the SLN. 

Results: Twenty patients among 130 met the inclusion criteria. SLN SPECT/CT images were helpful for locating the SLN on 18F-FDG PET/CT images in all 20 patients. Histopathologic analysis of the SLNs demonstrated metastasis in 7 patients and no metastasis in 13. There was mild (visible) 18F-FDG uptake in the SLN (SUVmax, 1.2-4.1; metastatic deposit size, 6-8 mm) in 6 of 7 patients with SLN metastasis (85.7%). There was no or only faint 18F-FDG uptake in the SLN (SUVmax < 1) in 9 of 13 patients with no SLN metastasis (69.2%). Receiver-operating-characteristic curve analysis indicated that the SUVmax cutoff for differentiating SLN-positive from -negative cases was 0.85 (sensitivity, 85.7%; specificity, 61.5%; area under the curve, 0.747; P < 0.05). 

Conclusion: Combined evaluation of 18F-FDG PET/CT and SPECT/CT images to assess 18F-FDG uptake, particularly in the SLN, is a new image analysis technique to detect early metastatic disease in the axillary lymph nodes in breast cancer. Although this technique does not currently seem feasible for use in routine practice, mainly because of the limitations of current PET/CT technology in detecting small tumors, it is an interesting image analysis technique to be aware of for possible future use.

Keywords: 18F-FDG; PET/CT; SPECT/CT; breast cancer; sentinel lymph node.


Similar articles

Prediction of Extracapsular Invasion at Metastatic Sentinel Nodes and Non-sentinel Lymph Nodal Metastases by FDG-PET in Cases with Breast Cancer.

Fujii T, Yajima R, Tatsuki H, Kuwano H.Anticancer Res. 2016 Apr;36(4):1785-9.PMID: 27069160

Factors affecting the accuracy of 18F-FDG PET/CT in evaluating axillary metastases in invasive breast cancer.

Kutluturk K, Simsek A, Comak A, Gonultas F, Unal B, Kekilli E.Niger J Clin Pract. 2019 Jan;22(1):63-68. doi: 10.4103/njcp.njcp_198_18.PMID: 30666022

Discordant results in 18F-FDG PET/CT and ultrasound-based assessment for axillary lymph node metastasis detection: A large retrospective analysis in 560 patients with breast cancer.

Parisse-Di Martino S, Faure C, Mognetti T.Cancer Treat Res Commun. 2021;27:100344. doi: 10.1016/j.ctarc.2021.100344. Epub 2021 Feb 20.PMID: 33636590

FDG-PET for axillary lymph node staging in primary breast cancer.

Crippa F, Gerali A, Alessi A, Agresti R, Bombardieri E.Eur J Nucl Med Mol Imaging. 2004 Jun;31 Suppl 1:S97-102. doi: 10.1007/s00259-004-1531-z. Epub 2004 May 5.PMID: 15133635 Review.

18 F-FDG PET/CT imaging of small intestinal metastasis from pulmonary sarcomatoid carcinoma: Brief report and review of the literature.

Xie X, Tu N, Wang Q, Cheng Z, Han X, Bu L.Thorac Cancer. 2020 Aug;11(8):2325-2330. doi: 10.1111/1759-7714.13468. Epub 2020 May 15.PMID: 32410331 Free PMC article. Review.


Cited by

Prediction of Metastasis in the Axillary Lymph Nodes of Patients With Breast Cancer: A Radiomics Method Based on Contrast-Enhanced Computed Tomography.

Yang C, Dong J, Liu Z, Guo Q, Nie Y, Huang D, Qin N, Shu J.Front Oncol. 2021 Sep 20;11:726240. doi: 10.3389/fonc.2021.726240. eCollection 2021.PMID: 34616678 Free PMC article.

Is there a difference in FDG PET findings of invasive ductal carcinoma of the breast with and without coexisting DCIS?

Sarikaya I, Sarikaya A, Albatineh AN, Tastekin E, Sezer YA.Asia Ocean J Nucl Med Biol. 2020 Winter;8(1):27-35. doi: 10.22038/aojnmb.2019.41658.1284.PMID: 32064280 Free PMC article.


KMEL References